NEW TOOL FOR PREVENTIVE MEDICINE: DETECTING ALZHEIMER’S BEFORE IT BECOMES A DISEASE

TGS is valorising a human relevant test method, based on a specific biomarker profile representing Alzheimer’s related neuronal processes before cell death occurs.


ToxGenSolutions BV

Erwin L Roggen (CEO): More than 25 years of industrial experience (including 15 years as a manager) in the development, implementation and use of animal-free methods; Self-employed since 2013 (www.3rsmc-aps.com) with the mission to valorise promising animal-free methods; Founder and co-owner (2011) of the listed company SenzaGen AB (Lund, Sweden) (www.senzagen.com), specialized in cell-based identification methods for allergens. profile: http://www.linkedin.com/profile/view?id=23021602&trk=tab_pro

Skriv et svar

Din e-mailadresse vil ikke blive publiceret.